Bioprocess Technology Market Insight, Size, Value, Demand, Covid 19 Pandemic Impact, Regional Framework, Research Methodology and Forecast To 2028
Healthcare to
Impact and Propel Global Bioprocess Technology
Market Growth: Reveals MRFR
Bioprocess
Technology Market is witnessing at present
an unprecedented growth due to revolutionary changes effected upon it by
technological advancements. The impact is aptly
backed by demands generated by the healthcare sector. The global
Bioprocess Technology market is expected to witness significant growth during
the forecast period (2017-2022), reveals Market Research Future (MRFR) in a
detailed analysis of the said market. Bioprocess
Technology involves deriving living cells or components and obtains desired results to boost
pharmaceuticals or chemical sector. The report incorporates multiple factors
that can promote Bioprocess Technology market further such as its growing use
in developing new drugs & treatments, food processing, thermal design of
biomedical devices, and effective
application in pollution control & global warming. An in-depth review of
the segments has also been included for a
better understanding of the bioprocess technology consultants market in coming years.
However, the regulatory process often delays the approval of
new drugs which can increase the production cost by a significant margin. This can
put a leash on the expected Bioprocess
Technology Market growth during the forecast
period.
Key Players:
Key players of the Bioprocess Technology market profiled in this
report are Merck Millipore (Germany), Thermo Fisher Scientific, Inc. (U.S.),
Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Lonza Group
AG (Switzerland), Sartorius Stedim Biotech S.A (France), Corning, Inc. (U.S.),
Bio-Rad Laboratories (U.S.), Charles River Laboratories (U.S.), and
others.
Segmentation:
The global Bioprocess Technology market can be segmented by
type, application, and end-users.
Type-based
segmentation of
the Bioprocess Technology market includes
cell culture, cell expansion, flow cytometry, cell line development, and virus infiltration. Cell culture has
diverse application in various sectors which gives it much traction, and it has become a necessary part in treating
chronic diseases.
Application-wise,
the Bioprocess Technology market comprises biopharmaceuticals, specialty
products, industrial chemicals, and
environment management aid. Biopharmaceuticals’ prosperous run is to continue
owing to its widespread functioning area as it has impacted common medicines to
chronic diseases. Furthermore, petrochemicals can propel the demand for
industrial chemicals in coming years.
Based
on end-users, the Bioprocess Technology
market
consists hospitals, research labs and
centers, medical institutions and others. Research labs and centers to gain the
most owing to private and government investments in the field.
Regional Analysis:
Region-specific
analysis of the Bioprocess Technology
market includes North America, Europe, Asia Pacific (APAC), and the Middle East
& Africa (MEA).
North
America’s growth can be attributed to its
ability to fetch the maximum revenue in the global market. Infrastructural
superiority can be considered as a boon
for the regional market. Furthermore, healthcare is receiving much funding
which is directly impacting the Bioprocess
Technology market by generating demand for pharmaceutical drugs.
Governments and private investors are also spending much in search for new
Bioprocess Technology-based products.
Europe is also drawing
significant attention from the global market by providing excellent infrastructure
for research and development in this sector. However, the APAC is the fastest
growing region and is touted to influence the market considerably in coming
years. Growing population and revamped healthcare sector can provide the
much-needed thrust to the regional market.
Market
Insight:
Strategies employed by the bigshots in the sector help in both individual
and holistic growth of the Bioprocess Technology
market. These strategies include mergers, acquisitions, product launch, and other methods and better the market
portfolio of companies. For instance, Charles River Laboratories has recently
acquired MPI Research, a non-clinical contract research organization (CRO) that
provides testing services to biopharmaceutical and medical device companies
across the globe. Their market rival, Thermo Fisher Scientific, Inc. signed an
agreement with Roper Technologies to acquire Gatan, which can ensure their
market profile upgradation.
Industry
News:
Novartis and Gilead/Kite have
got approval for their respective
medicines Kymriah and Yescarta, two cell-therapy biotherapeutic medicine which
can significantly trigger monoclonal antibody industry prospect.
About US:
Market Research Future (MRFR) enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment